Efficacy of selective mineralocorticoid and glucocorticoid agonists in canine septic shock
- 1 January 2012
- journal article
- laboratory investigations
- Published by Wolters Kluwer Health in Critical Care Medicine
- Vol. 40 (1) , 199-207
Abstract
Objective: Corticosteroid regimens that stimulate both mineralocorticoid and glucocorticoid pathways consistently reverse vasopressor-dependent hypotension in septic shock but have variable effects on survival. The objective of this study was to determine whether exogenous mineralocorticoid and glucocorticoid treatments have distinct effects and whether the timing of administration alters their effects in septic shock. Design, Setting, Subjects, and Interventions: Desoxycorticosterone, a selective mineralocorticoid agonist; dexamethasone, a selective glucocorticoid agonist; and placebo were administered either several days before (prophylactic) or immediately after (therapeutic) infectious challenge and continued for 96 hrs in 74 canines with staphylococcal pneumonia. Measurements and Main Results: Effects of desoxycorticosterone and dexamethasone were different and opposite depending on timing of administration for survival (p = .05); fluid requirements (p = .05); central venous pressures (p ≤ .007); indicators of hemoconcentration (i.e., sodium [p = .0004], albumin [p = .05], and platelet counts [p = .02]); interleukin-6 levels (p = .04); and cardiac dysfunction (p = .05). Prophylactic desoxycorticosterone treatment significantly improved survival, shock, and all the other outcomes stated, but therapeutic desoxycorticosterone did not. Conversely, prophylactic dexamethasone was much less effective for improving these outcomes compared with therapeutic dexamethasone with the exception of shock reversal. Prophylactic dexamethasone given before sepsis induction also significantly reduced serum aldosterone and cortisol levels and increased body temperature and lactate levels compared with therapeutic dexamethasone (p ≤ .05), consistent with adrenal suppression. Conclusions: In septic shock, mineralocorticoids are only beneficial if given prophylactically, whereas glucocorticoids are most beneficial when given close to the onset of infection. Prophylactic mineralocorticoids should be further investigated in patients at high risk to develop sepsis, whereas glucocorticoids should only be administered therapeutically to prevent adrenal suppression and worse outcomes.Keywords
This publication has 39 references indexed in Scilit:
- Aldosterone Abrogates Nuclear Factor κB–Mediated Tumor Necrosis Factor α Production in Human Neutrophils via the Mineralocorticoid ReceptorHypertension, 2010
- Defining normal adrenal function testing in the intensive care unit setting: A canine study*Critical Care Medicine, 2010
- The effects of steroids during sepsis depend on dose and severity of illness: an updated meta-analysisClinical Microbiology and Infection, 2009
- Effects of intra-aortic balloon counterpulsation in a model of septic shock*Critical Care Medicine, 2009
- Mineralocorticoid effects due to cortisol inactivation overload explain the beneficial use of hydrocortisone in septic shockMedical Hypotheses, 2008
- Plasma sodium stiffens vascular endothelium and reduces nitric oxide releaseProceedings of the National Academy of Sciences, 2007
- The Mineralocorticoid Receptor: Insights into its Molecular and (Patho)Physiological BiologyNuclear Receptor Signaling, 2007
- Glucocorticoid Receptor-Dependent Gene Regulatory NetworksPLOS Genetics, 2005
- Hypertensive mechanisms associated with centrally administered aldosterone in dogs.Hypertension, 1988
- Experimental aldosterone hypertension in the dog.Hypertension, 1982